An official website of the United States government

Here's how you know

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

COVID-19

Expand for resources

PAR-21-123 - Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 2

Active NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Advancing Research for Amyotrophic Lateral Sclerosis (ALS)	NOT-NS-23-062	NINDS	Feb 6, 2023	Jun 24, 2024	R61/R33, R41/R42, R43/R44
HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery	NOT-NS-22-095	NINDS , NCCIH , NCI , NEI , NIA , NIAAA , NIAMS , NICHD , NIDCR , NIDDK	Jul 13, 2022	Jun 25, 2025	R61/R33

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)